ÂÜÀòÂÒÂ×

Colm Galligan is an accomplished medical professional and business leader with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as the Managing Director at Asgard Sciences Ltd since January 2024 and as Chief Medical Officer & Co-Founder of RemedyBio since January 2020, Colm has a proven track record in roles such as Medical Director at MSD from December 2007 to August 2019 and at Novo Nordisk from August 2003 to November 2007. Colm’s expertise encompasses medical affairs, clinical research, health technology assessment, regulatory affairs, and pharmacoeconomics. Educational qualifications include an Accredited Chartered Director designation from the Institute of Directors, a Fellowship in Pharmaceutical Medicine, and multiple degrees in medicine and business administration from esteemed institutions, including Trinity College Dublin and University College Dublin.